ARCA biopharma, Inc. Recorded Big Gain
Thu, Sep 05, 2024 at 07:46 PM
ARCA biopharma, Inc. (ABIO:NASDAQ) jumped higher at $28.8, a gain of 1052%. On Thu, Sep 05, 2024, ABIO:NASDAQ hit a New 2-Week Intraday Low of $2.25. The stock appeared on our News Catalysts scanner on Tue, Sep 03, 2024 at 08:50 AM in the 'MERGER' category. From Thu, Aug 22, 2024, the stock recorded 33.33% Up Days and 70.00% Green Days
About ARCA biopharma, Inc. (ABIO:NASDAQ)
ARCA biopharma Inc is a biopharmaceutical company. The Company is engaged in developing genetically-targeted therapies for cardiovascular diseases. Its product candidate is Gencaro.
Top 10 Gainers:
- ARCA biopharma, Inc. (ABIO:NASDAQ), 1052%
- Eastside Distilling, Inc. (EAST:NASDAQ), 89.22%
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 81.4%
- Altisource Asset Management Corporation (AAMC:NYSEMKT), 65.18%
- Inspire Veterinary Partners Inc. (IVP:NASDAQ), 62.95%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 60%
- BOQI International Medical Inc. (BIMI:NASDAQ), 50%
- SRM Entertainment Inc. (SRM:NASDAQ), 40.33%
- Tenon Medical Inc. (TNON:NASDAQ), 37.49%
- Ryde Group Ltd. Class A (RYDE:NYSEMKT), 33.85%